NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization (EUA) to Nanobiosym's Gene-Radar Zika virus test, the company said today.

According to Nanobiosym, the test is based on its Gene-Radar portable diagnostic platform and can qualitatively detect Zika RNA in human serum from individuals meeting the Centers for Disease Control and Prevention's Zika virus clinical and/or epidemiological criteria.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Feb
27

In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep. 

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.